BusinessPostCorner.com
No Result
View All Result
Monday, July 14, 2025
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources
BusinessPostCorner.com
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources
No Result
View All Result
BusinessPostCorner.com
No Result
View All Result

One of the most shorted stocks on the market just leapt 99%

May 10, 2024
in Business
Reading Time: 2 mins read
A A
0
One of the most shorted stocks on the market just leapt 99%
ShareShareShareShareShare

Novavax Inc.’s record one-day gain is forcing some short sellers betting against the stock to exit their positions at a loss. 

Shares of the vaccine maker soared 99% Friday, after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot. The move boosts a stock that had plunged about 99% — prior to the deal — from its 2021 peak amid waning demand for its Covid vaccine.

Friday’s surge, however, delivered paper losses of about $255 million to short sellers, according to data from S3 Partners LLC. The biotech stock is a crowded position for short sellers, with less than 1 million shares available to borrow to support new sales, according to S3. 

The rapid gain in Novavax shares puts traders at risk of getting squeezed, a phenomenon where short sellers are forced to buy back the stock to unload their losing positions. The short covering drives the company’s share price higher, adding further pressure to the contrarian traders. 

“We expect a rib-crunching short squeeze in Novavax with short sellers taking huge losses on the market open and closing out positions throughout the day,” said Ihor Dusaniwsky, managing director of predictive analytics at S3.

Novavax is among the most heavily shorted stocks in the US with over $50 million of short interest.

“Many short sellers may hold on for a while and look for better exit prices over the next few days,” Dusaniwsky added.

For its part, Novavax will gain $500 million in upfront payments as well as up to $700 million if development, regulatory and launch milestones are met from the Sanofi licensing agreement. The new cash infusion spurred an upgrade by JPMorgan’s Eric Joseph, who views the deal as “transformative to Novavax’s overall business.”

Joseph, who moved to a neutral rating from an underweight, expects many of Novavax’s commercial growing pains suffered in 2023 and 2024 to be much less of a factor with Sanofi running the commercialization from 2025 onwards.

Still, Wall Street analysts remain divided on the stock — with three buy ratings, three saying to hold and none recommending investors to sell — according to data compiled by Bloomberg. The average price target of $17 implies about 91% upside in the next 12 months from where shares are currently trading.

Subscribe to the CFO Daily newsletter to keep up with the trends, issues, and executives shaping corporate finance. Sign up for free.

Credit: Source link

ShareTweetSendPinShare
Previous Post

US set to impose 100% tariff on Chinese electric vehicle imports

Next Post

Financial stress is making us mentally and physically ill. Here’s how to cope

Next Post
Financial stress is making us mentally and physically ill. Here’s how to cope

Financial stress is making us mentally and physically ill. Here’s how to cope

How Domino’s and Best Western use onboarding to retain talent

How Domino’s and Best Western use onboarding to retain talent

July 11, 2025
Inside Home Depot’s .3 billion pivot toward the professional trade

Inside Home Depot’s $4.3 billion pivot toward the professional trade

July 10, 2025
Ethereum Price Prediction: ETH Leads the Charge Above ,000 – Has Crypto Summer Season Officially Begun?

Ethereum Price Prediction: ETH Leads the Charge Above $3,000 – Has Crypto Summer Season Officially Begun?

July 12, 2025
CFO optimism dropped in Q2

CFO optimism dropped in Q2

July 8, 2025
IRS allows churches to endorse political candidates

IRS allows churches to endorse political candidates

July 8, 2025
Volodymyr Zelenskyy nominates new Ukraine PM in major reshuffle

Volodymyr Zelenskyy nominates new Ukraine PM in major reshuffle

July 14, 2025
BusinessPostCorner.com

BusinessPostCorner.com is an online news portal that aims to share the latest news about following topics: Accounting, Tax, Business, Finance, Crypto, Management, Human resources and Marketing. Feel free to get in touch with us!

Recent News

EU ministers rip Trump’s 30% tariffs as ‘absolutely unacceptable’

EU ministers rip Trump’s 30% tariffs as ‘absolutely unacceptable’

July 14, 2025
Germany Sold 54,000 BTC at .9K Last Year – You Won’t Believe How Much They’re Worth Now

Germany Sold 54,000 BTC at $57.9K Last Year – You Won’t Believe How Much They’re Worth Now

July 14, 2025

Our Newsletter!

Loading
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2023 businesspostcorner.com - All Rights Reserved!

No Result
View All Result
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources

© 2023 businesspostcorner.com - All Rights Reserved!